SMU
PCYC

Signet Management USA’s PHARMACYCLICS INC PCYC Stock Holding History

Signet Management USA’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$11K Buy
+100
New +$12.1K 0.01% 161

Other funds holding PCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Signet Management USA's PCYC Position: Q4 2013 in Review

Signet Management USA opened a new position in PHARMACYCLICS INC (PCYC) in Q4 2013: 100 shares worth $11K. The stake represents 0.01% of the portfolio and ranks #161 among its holdings.

253 funds tracked by Wall St. Rank hold PCYC as of Q4 2013.

  • Signet Management USA held 100 shares of PHARMACYCLICS INC worth $11K as of Q4 2013.
  • PHARMACYCLICS INC was a new Signet Management USA position in Q4 2013.
  • PHARMACYCLICS INC made up 0.01% of Signet Management USA's portfolio in Q4 2013, its #161 holding.
  • 253 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q4 2013.

Based on Signet Management USA's 13F filing for Q4 2013, filed 11 Feb 2014.